Search Results for "Sapien Valve Tricuspid Position"
Original Source: Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks.
Aims: We describe the first report of an Edwards SAPIEN valve implanted in a tricuspid bioprosthesis from the femoral vein. We highlight the feasibility of this previously avoided approach and the techniques involved. Methods and results: A 61-year-old woman with multiple valve replacements for rheumatic heart disease presented with NHYA IV dyspnoea secondary to a severely stenosed tricuspid bioprosthesis. After failed aggressive medical therapy and surgical turn down, an Edwards SAPIEN XT valve was deploye...
Matching Channels
Tricuspid stenosis is a narrowing of the tricuspid valve opening that increases resistance to blood flow from the right atrium to the right ventricle.Over many years, the right atrium enlarges becau...
Tricuspid regurgitation (tricuspid incompetence, tricuspid insufficiency) is leakage of blood backward through the tricuspid valve each time the right ventricle contracts.Tricuspid regurgitation is...
Matching News
Device for Non-Surgical Tricuspid Valve Annuloplasty
This is a non-surgical tricuspid annuloplasty to treat functional tricuspid valve regurgitation, meaning regurgitation with intact valve leaflets. The device is delivered using novel catheter techniq...
ACC: Sapien XT Effective for High Risk TAVR (CME/CE)
SAN FRANCISCO (MedPage Today) -- The second generation transcatheter valve, Sapien XT, appears to be as effective as the FDA-approved Sapien valve and may be easier to implant.
Redesigned Transcatheter Heart Valve Shows Improvements, Study
Edwards Lifesciences' redesigned non-invasive heart valve replacement system - Sapien XT - showed good performance and was associated with fewer complications compared to the original Sapien, clinical...
Evidence-based surgical management of acquired tricuspid valve disease
Tricuspid valve disease generally occurs secondary to other cardiac conditions, particularly mitral valve regurgitation or stenosis. Repair gives excellent results, but a substantial proportion of pat...
Approval expanded for sapien artificial heart valve
(HealthDay)—U.S. Food and Drug Administration approval for the Sapien Transcatheter Heart Valve has been expanded to include additional people with aortic valve stenosis, the medical term for a narr...
UPDATE 1-Redesigned Edwards heart valve shows improvement in study
* Sapien XT, Sapien show similar death, stroke rates at 1 yr * Fewer complications seen with newer XT model after 30 days By Bill Berkrot SAN FRANCISCO, March 10 (Reuters) - A smaller, r...
Sapien Valve Ok'd for High-Risk Surgery Patients
WASHINGTON (MedPage Today) -- The FDA on Friday expanded the indication for the Sapien Transcatheter Heart Valve so that it can now be used "on label" for patients who are high-risk candidates for sur...
TAVI: No Safety Edge for Sapien Valve (CME/CE)
(MedPage Today) -- Medtronic's CoreValve system was as safe as Edward Lifesciences' Sapien valve when both long and short-term death rates were compared.
Matching PubMed Articles
Aims: We describe the first report of an Edwards SAPIEN valve implanted in a tricuspid bioprosthesis from the femoral vein. We highlight the feasibility of this previously avoided approach and the tec...
Pericardial patch valve in the tricuspid position in an infant.
A 10-month-old infant with severe tricuspid valve disease due to staphylococcal bacterial endocarditis, underwent surgical replacement of the valve. The new valve was fashioned using an autologous per...
The purpose of this study was to evaluate the safety and effectiveness of the Edwards SAPIEN transcatheter heart valve (Edwards Lifesciences LLC, Irvine, California) in the pulmonary position in patie...
The aim of this study was to compare outcomes after transfemoral transcatheter aortic valve implantation with the Medtronic CoreValve (MCV) versus the Edwards SAPIEN/SAPIEN XT transcatheter heart valv...
Two melodies in concert: Transcatheter double-valve replacement.
Percutaneous pulmonary valve implantation (PPVI) has been established as a valuable treatment option for elder children and adolescents with conduit failure in the right ventricular outflow tract (RVO...
